ESAT-6/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of Mycobacterium tuberculosis Infection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia
- 1 May 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (5) , 2070-2074
- https://doi.org/10.1128/jcm.43.5.2070-2074.2005
Abstract
Overlapping peptides of Mycobacterium tuberculosis antigens ESAT-6 and CFP-10 offer increased specificity over the purified protein derivative skin test when they were used in an ex vivo enzyme-linked immunospot (ELISPOT) assay for gamma interferon detection for the diagnosis of M. tuberculosis infection from recent exposure. We assessed whether equivalent results could be obtained for a fusion protein of the two antigens and whether a combined readout would offer increased sensitivity in The Gambia. We studied the ELISPOT assay results for 488 household contacts of 88 sputum smear-positive tuberculosis (TB) cases. The proportions of subjects positive by each test and by the tests combined were assessed across an exposure gradient, defined according to sleeping proximity to a TB case. Eighty-eight (18%) subjects were positive for CFP-10 peptides, 148 (30%) were positive for ESAT-6 peptides, 161 (33%) were positive for both peptides, and 168 (34%) were positive for the fusion protein; 188 (39%) subjects had either a positive result for a peptide or a positive result for the fusion protein. There was reasonable agreement between the peptide and the protein results (kappa statistic = 0.78) and no significant discordance ( P = 0.38). There was a strong correlation between the fusion protein and combined peptide spot counts ( r = 0.9), and responses to the peptide and the proteins all increased significantly according to M. tuberculosis exposure. The proportion of subjects positive for either the pool of peptides or the fusion protein offered maximum sensitivity, being significantly higher than the proportion of subjects positive for ESAT-6 peptides alone ( P = 0.007). A fusion protein of ESAT-6 and CFP-10 is equivalent to overlapping peptides for the diagnosis of latent M. tuberculosis infection. Use of a combination of peptides and fusion protein offers improved sensitivity.Keywords
This publication has 14 references indexed in Scilit:
- An Antigenic Peptide Produced by Peptide Splicing in the ProteasomeScience, 2004
- Large‐Scale Evaluation of Enzyme‐Linked Immunospot Assay and Skin Test for Diagnosis ofMycobacterium tuberculosisInfection against a Gradient of Exposure in The GambiaClinical Infectious Diseases, 2004
- Immune recognition of a human renal cancer antigen through post-translational protein splicingNature, 2004
- Conclusive Evidence That the Major T-cell Antigens of theMycobacterium tuberculosis Complex ESAT-6 and CFP-10 Form a Tight, 1:1 Complex and Characterization of the Structural Properties of ESAT-6, CFP-10, and the ESAT-6·CFP-10 ComplexJournal of Biological Chemistry, 2002
- Tuberculin Skin Testing Compared with T-Cell Responses to Mycobacterium tuberculosis -Specific and Nonspecific Antigens for Detection of Latent Infection in Persons with Recent Tuberculosis ContactClinical and Diagnostic Laboratory Immunology, 2001
- Enumeration of T Cells Specific for RD1‐Encoded Antigens Suggests a High Prevalence of LatentMycobacterium tuberculosisInfection in Healthy Urban IndiansThe Journal of Infectious Diseases, 2001
- More rigour needed in trials of new diagnostic agents for tuberculosisThe Lancet, 2000
- Detection of Active Tuberculosis Infection by T Cell Responses to Early‐Secreted Antigenic Target 6‐kDa Protein and Culture Filtrate Protein 10The Journal of Infectious Diseases, 2000
- Purification of His-Tagged Proteins by Immobilized Chelate Affinity Chromatography: The Benefits from the Use of Organic SolventProtein Expression and Purification, 2000
- Differential T cell responses toMycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donorsEuropean Journal of Immunology, 1998